by National Cerebral and Cardiovascular Center Credit: JAMA Network Open/ National Cerebral and Cardiovascular Center A recent study demonstrated the safety of cilostazol in patients with mild cognitive impairment (MCI), but did not demonstrate any efficacy in preventing disease progression. However, after administration of cilostazol, the blood concentrations of the albumin and β-amyloid complex (albumin-Aβ...
